Taiko Pharmaceutical News

Taiko Pharmaceutical: Summary of financial results for the 1st quarter of 2024

May 10 02:30 ET

Taiko Pharmaceutical: Plans for compliance with listing maintenance standards

Mar 19 02:30 ET

Taiko Pharmaceutical: Independent Officer Registration Form

Mar 7 01:30 ET

Taiko Pharmaceutical: Notice regarding changes in officers

Feb 20 01:30 ET

Taiko Pharmaceutical: Notice regarding a decrease in the amount of capital (capital reduction)

Feb 20 01:30 ET

Taiko Pharmaceutical: Summary of Financial Results 2023

Feb 9 01:30 ET

Taiko Pharmaceutical: Notice regarding completion of exercise of stock acquisition rights with exercise price amendment clauses and monthly exercise status

Jan 23 02:30 ET

Taiko Pharmaceutical: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clauses

Jan 5 02:30 ET

Taiko Pharmaceutical: Notice Concerning Continued Reduction in Executive Remuneration

Dec 22, 2023 01:30 ET

Taiko Pharmaceutical: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clause

Dec 1, 2023 02:30 ET

Taiko Pharmaceutical: Notice regarding the establishment of the Nomination and Remuneration Committee

Nov 21, 2023 01:30 ET

Taiko Pharmaceutical: Summary of Financial Results for the third quarter 2023

Nov 10, 2023 01:30 ET

Taiko Pharmaceutical: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clause

Nov 1, 2023 03:30 ET

Taiko Pharmaceutical: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clause

Oct 2, 2023 03:30 ET

Taiko Pharmaceutical: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clauses

Sep 1, 2023 03:30 ET

Taiko Pharmaceutical: Notice Concerning Mass Exercise of Stock Acquisition Rights with Exercise Price Amendment Clause

Aug 15, 2023 03:30 ET

Taiko Pharmaceutical: Summary of Financial Results for the second quarter 2023

Aug 10, 2023 02:30 ET

Taiko Pharmaceutical: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clause

Aug 1, 2023 03:30 ET

Taiko Pharmaceutical: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clause

Jul 3, 2023 03:30 ET

Taiko Pharmaceutical: Notice Concerning Mass Exercise of Stock Acquisition Rights with Exercise Price Amendment Clause

Jun 27, 2023 03:30 ET